Preventive and therapeutic use of pneumococcal vaccine in industrial workers with chronic pulmonary diseases
https://doi.org/10.18093/0869-0189-2007-0-3-81-86
Abstract
The efficacy of immunization against various pathogens has been proved in a long term practice worldwide. A delayed effect of vaccination with pneumococcal vaccine Pneumo 23 in 243 workers in a large industrial enterprise in Chelyabinsk has been analyzed in the article. One year after the vaccination a second examination was carried out in 102 persons (38 with chronic simple bronchitis (CSB) and 64 with COPD) and 1.5 years after vaccination it was done in 92 persons (59 persons with CSB and 33 with COPD) The efficacy of the vaccination was assessed by the rate, length and severity of exacerbations of chronic respiratory diseases, as well as by clinical symptoms, results of physical examination, lung function parameters, and quality of life. The 1st control group included 33 patients with COPD, the 2nd control group included 57 patients with chronic bronchitis working in the same enterprise. The groups were compatible for age, length of work, duration of the disease and FEV1 . After immunization the exacer bation rate in the vaccinated patients with CSB decreased by 3.6 and 2.5 times within 1 and 1.5 years correspondingly (р < 0.01). The vaccinated patients with COPD demonstrated a 2.4 fold and a 2.2 fold reduction respectively (р < 0.01). The duration of exacerbations in patients with CSB decreased by 1.6 and 1.1 respectively (р < 0.01) and by 1.78 and 1.2 in patients with COPD respectively (р < 0.01). Of vaccinated patients with COPD 39.4 % did not experience any exacerbations during the follow up period compared to 0 % in the control group. The quality of life of the vaccinated patients improved in terms of physical activity, general and psychological health, vitality, reduction of discomfort. The results allow us to recom mend pneumococcal vaccination for wide implementation in high risk industrial workers.
About the Authors
G. L. Ignatova
Кафедра терапии, фтизиопульмонологии и профпатологии ГОУ ДПО УГМАДО Росздрава
Russian Federation
Russian Federation
N. S. Fedosova
Кафедра терапии, фтизиопульмонологии и профпатологии ГОУ ДПО УГМАДО Росздрава
Russian Federation
Russian Federation
L. A. Stepanishcheva
Кафедра терапии, фтизиопульмонологии и профпатологии ГОУ ДПО УГМАДО Росздрава
Russian Federation
Russian Federation
References
1. Мешкова Р.Я. Иммунопрофилактика: Руководство для врачей. Смоленск: Русич; 1999.
2. Schlech W.F. III, Ward J.I., Band J.D.et al. Bacterial meningitis in the United States, 1878 through 1981, The National Bacterial Meningitis Surveillance Study. J. A. M. A. 1985, 253: 1749–5754.
3. Sims R.V., Boyko E.J., Maislin G. et al. The role of age in susceptibility to pneumococcal infections. Age and Ageing 1992; 21: 357–361.
4. Breiman R.F., Butler J.C., Tenover F.C. et al. Emergence of drug resistant pneumococcal infections in the United States. J. A. M. A. 1994; 271: 1831–1835.
5. Hoffman J., Cetron M.S., Farley M.M. et al. The prevalence of drug resistant Streptococcus pneumonia in the Atlanta. N. Engl. J. Med. 1995; 333: 481–486.
6. Centers for Disease Control. Pneumococcal polysaccharide vaccine: recommendations of the Immunization. Practices Advisory Committee (ACIP). Morb. Mortal Wkly Rep. 1989; 38: 64–68, 73–76.
7. Дворецкий Л.И. Инфекция и ХОБЛ. Consilium Medicum 2001; 3 (12): 587–584.
8. Ansaldi F., Turello V., Lai P. et al. Effectiveness of a 23 valent polysaccharide vaccine in preventing pneumonia and non invasive pneumococcal infection in elderly people: a large scale retrospective cohort study. J. Int. Med. Res. 2005; 33 (5): 490–500.
9. Шмелев Е.И. Бактериальная иммунокоррекция при хроническом бронхите и ХОБЛ. Пульмонол. и аллер гол. Атмосфера 2005; 1: 33–38.
10. Протокол ведения больных ХОБЛ. Проблемы стандартизации в здравоохранении 2007; 1: 10–18.
11. Авдеев С.Н. Обострение ХОБЛ: значение инфекцион ного фактора и антибактериальная терапия. Рус. мед. журн. 2003; 11 (22): 1205–1210.
12. Sethi S., Murphy T.F. Bacterial infection in chronic obstruc tive pulmonary disease in 2000: a state of the art review. Clin. Microbiol. Rev. 2001; 14 (2): 336–363.
13. Eller J., Ede A., Schaberg T. et al. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113: 1542–1548.
14. Miravitlles M., Espinosa C., Fernandez1Laso E. et al. Relationship between bacterial flora in sputum and func tional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999; 116: 40–46.
15. Чучалин А.Г. (ред.) Клинические рекомендации. Хро ническая обструктивная болезнь легких. М.; 2003. 69–93.
16. Рыжов А.А., Костинов М.П., Магаршак О.О. Примене ниевакцин против пневмококковой и гемофильной типа b инфекций у лиц с хронической патологией. Эпидемиол. и вакцинопрофилакт. 2004; 6 (19): 24–27.
17. Austrian R. Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines. Report DAB VDP 12 84. Bethesda: National Institute of Health; 1980.
18. Геппе Н.А., Малахов А.Б. Пневмококковая инфекция респираторной системы в детском возрасте: Практическое руководство для врачей. М.; 2005.
19. Мельниченко П.И., Мосягин В.Д., Жоголев С.Д. Применение пневмококковой вакцины пневмо 23 для про филактики инфекций респираторного тракта и лор органов в воинских коллективах. Бюл. "Вакцинация" 2003; 5 (29): 9–11.
20. Зарубина Е.Г., Турковский Ю.В. Профилактика заболеваемости пневмониями среди военнослужащих по призыву. В кн.: Российское респираторное о-во. 15 й Национальный конгресс: Сборник тезисов. 2005. 9.
21. Fisman D.N., Abrutyn E., Spaude K.A. et al. Prior pneumo coccal vaccination is associated with reduced death, com plications, and length of stay among hospitalized adults with community acquired pneumonia. Clin. Infect. Dis. 2006; 42 (8): 1093–1101.
22. Цеймах И.Я., Мартыненко Т.И., Параева О.С. и др. Эффективность вакцинопрофилактики респираторных инфекций у больных с ХОБЛ. В кн.: Российское Респираторное о во. 15й Национальный конгресс: Сборник тезисов. 2005. 239.
Review
For citations:
Ignatova G.L., Fedosova N.S., Stepanishcheva L.A. Preventive and therapeutic use of pneumococcal vaccine in industrial workers with chronic pulmonary diseases. PULMONOLOGIYA. 2007;(3):81-86. (In Russ.) https://doi.org/10.18093/0869-0189-2007-0-3-81-86
Views:
549
Email this article 